208 related articles for article (PubMed ID: 16902188)
1. Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction.
Yang Y; Chen M; Georgeson KE; Harmon CM
Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R235-41. PubMed ID: 16902188
[TBL] [Abstract][Full Text] [Related]
2. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).
Guzmán M; Lo Verme J; Fu J; Oveisi F; Blázquez C; Piomelli D
J Biol Chem; 2004 Jul; 279(27):27849-54. PubMed ID: 15123613
[TBL] [Abstract][Full Text] [Related]
3. The lipid messenger OEA links dietary fat intake to satiety.
Schwartz GJ; Fu J; Astarita G; Li X; Gaetani S; Campolongo P; Cuomo V; Piomelli D
Cell Metab; 2008 Oct; 8(4):281-288. PubMed ID: 18840358
[TBL] [Abstract][Full Text] [Related]
4. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
[TBL] [Abstract][Full Text] [Related]
5. CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice.
Guijarro A; Fu J; Astarita G; Piomelli D
Pharmacol Res; 2010 Jan; 61(1):27-33. PubMed ID: 19778614
[TBL] [Abstract][Full Text] [Related]
6. Feeding regulation by oleoylethanolamide synthesized from dietary oleic acid.
Igarashi M; Iwasa K; Yoshikawa K
Prostaglandins Leukot Essent Fatty Acids; 2021 Feb; 165():102228. PubMed ID: 33385936
[TBL] [Abstract][Full Text] [Related]
7. Role of endocannabinoids and their analogues in obesity and eating disorders.
Gaetani S; Kaye WH; Cuomo V; Piomelli D
Eat Weight Disord; 2008 Sep; 13(3):e42-8. PubMed ID: 19011363
[TBL] [Abstract][Full Text] [Related]
8. Effect of a high fat diet on lipid absorption and fatty acid transport in a rat model of short bowel syndrome.
Sukhotnik I; Gork AS; Chen M; Drongowski RA; Coran AG; Harmon CM
Pediatr Surg Int; 2003 Jul; 19(5):385-90. PubMed ID: 12721710
[TBL] [Abstract][Full Text] [Related]
9. Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine.
Fu J; Astarita G; Gaetani S; Kim J; Cravatt BF; Mackie K; Piomelli D
J Biol Chem; 2007 Jan; 282(2):1518-28. PubMed ID: 17121838
[TBL] [Abstract][Full Text] [Related]
10. Effect of low fat diet on lipid absorption and fatty-acid transport following bowel resection.
Sukhotnik I; Gork AS; Chen M; Drongowski RA; Coran AG; Harmon CM
Pediatr Surg Int; 2001 May; 17(4):259-64. PubMed ID: 11409158
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity.
Tutunchi H; Saghafi-Asl M; Ostadrahimi A
Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):543-552. PubMed ID: 31868943
[TBL] [Abstract][Full Text] [Related]
12. Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour.
Sihag J; Jones PJH
Obes Rev; 2018 Feb; 19(2):178-197. PubMed ID: 29124885
[TBL] [Abstract][Full Text] [Related]
13. Gut expression and regulation of FAT/CD36: possible role in fatty acid transport in rat enterocytes.
Chen M; Yang Y; Braunstein E; Georgeson KE; Harmon CM
Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E916-23. PubMed ID: 11595646
[TBL] [Abstract][Full Text] [Related]
14. Oleoylethanolamide differentially regulates glycerolipid synthesis and lipoprotein secretion in intestine and liver.
Pan X; Schwartz GJ; Hussain MM
J Lipid Res; 2018 Dec; 59(12):2349-2359. PubMed ID: 30369486
[TBL] [Abstract][Full Text] [Related]
15. Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide.
Azari EK; Ramachandran D; Weibel S; Arnold M; Romano A; Gaetani S; Langhans W; Mansouri A
Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(2):R167-78. PubMed ID: 24829501
[TBL] [Abstract][Full Text] [Related]
16. Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice.
Thabuis C; Destaillats F; Landrier JF; Tissot-Favre D; Martin JC
J Nutr Biochem; 2010 Oct; 21(10):922-8. PubMed ID: 19954948
[TBL] [Abstract][Full Text] [Related]
17. Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats.
Fu J; Kim J; Oveisi F; Astarita G; Piomelli D
Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R45-50. PubMed ID: 18434444
[TBL] [Abstract][Full Text] [Related]
18. Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome.
Igarashi M; Narayanaswami V; Kimonis V; Galassetti PM; Oveisi F; Jung KM; Piomelli D
Pharmacol Res; 2017 Mar; 117():75-81. PubMed ID: 28007570
[TBL] [Abstract][Full Text] [Related]
19. Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats.
Li L; Li L; Chen L; Lin X; Xu Y; Ren J; Fu J; Qiu Y
J Pharmacol Sci; 2015 Mar; 127(3):244-50. PubMed ID: 25837920
[TBL] [Abstract][Full Text] [Related]
20. Oleic acid-derived oleoylethanolamide: A nutritional science perspective.
Bowen KJ; Kris-Etherton PM; Shearer GC; West SG; Reddivari L; Jones PJH
Prog Lipid Res; 2017 Jul; 67():1-15. PubMed ID: 28389247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
